Home » Stocks » Lannett Company

Lannett Company, Inc. (LCI)

Stock Price: $7.01 USD -0.03 (-0.43%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 281.95M
Revenue (ttm) 545.74M
Net Income (ttm) -33.37M
Shares Out 40.22M
EPS (ttm) -0.87
PE Ratio n/a
Forward PE 11.74
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $7.01
Previous Close $7.04
Change ($) -0.03
Change (%) -0.43%
Day's Open 7.08
Day's Range 6.90 - 7.08
Day's Volume 173,668
52-Week Range 4.89 - 13.12

More Stats

Market Cap 281.95M
Enterprise Value 829.69M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 40.22M
Float 29.92M
EPS (basic) -0.86
EPS (diluted) -0.87
FCF / Share 2.72
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 37.26%
Payout Ratio n/a
Shares Short 9.38M
Short Ratio 24.66
Short % of Float 31.33%
Beta 1.46
PE Ratio n/a
Forward PE 11.74
P/FCF Ratio 2.68
PS Ratio 0.52
PB Ratio 0.93
Revenue 545.74M
Operating Income 19.56M
Net Income -33.37M
Free Cash Flow 105.06M
Net Cash -547.74M
Net Cash / Share -13.62
Gross Margin 36.14%
Operating Margin 3.58%
Profit Margin -6.10%
FCF Margin 19.25%
ROA 3.00%
ROE -10.48%
ROIC 1.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$7.33*
(4.56% upside)
Low
6.00
Current: $7.01
High
8.00
Target: 7.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue546655685633542407274151123107
Revenue Growth-16.73%-4.26%8.09%16.75%33.34%48.6%81.24%22.82%15.12%-
Gross Profit16524428930128630615457.4238.9523.32
Operating Income19.56-26214586.4513122688.0918.766.91-1.18
Net Income-33.37-27228.69-0.5844.7815057.1013.323.95-0.28
Shares Outstanding38.5937.7837.1336.8136.4435.8333.6628.4728.2626.76
Earnings Per Share-0.86-7.200.75-0.021.204.041.620.460.14-0.01
EPS Growth-----70.3%149.38%252.17%228.57%--
Operating Cash Flow11617611916513512945.1026.5011.12-6.20
Capital Expenditures-10.95-9.89-52.29-48.58-24.25-31.58-26.03-7.51-5.23-7.25
Free Cash Flow10516666.2411711196.9419.0718.995.89-13.45
Cash & Equivalents14414098.5914523921414651.1529.2324.66
Total Debt6927298399041,0621.011.146.517.167.82
Net Cash / Debt-548-589-741-759-82321314544.6422.0716.84
Assets1,1371,1871,5751,6031,764509343168143148
Liabilities8348539761,0421,21045.0048.0138.9431.2842.06
Book Value303334599561554463294129111106
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Lannett Company, Inc.
Country United States
Employees 954
CEO Timothy C. Crew

Stock Information

Ticker Symbol LCI
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NYSE: LCI

Description

Lannett Company develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Pharm Group, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.